Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Driven Financial Unveils New Express Funding for Small Business Owners
-
Solvd Inc. Appoints Scott Torrey to its Board of Directors
-
DeFi Technologies to Join Coinbase and Grayscale in Upcoming Panel Discussion at Bitcoin Investor Day, Moderated by Anthony Pompliano
-
FMC Corporation appoints executive leaders for North America and Latin America
-
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
-
Generac's Elizabeth Anderson recognized by the Manufacturing Institute for 2024 Women MAKE Awards
-
Titan Announces Q&A Session with Shareholders
-
LeddarTech Concludes Licensing Arrangement With Renesas
-
LENNAR INTRODUCES THE TOWNES AT BAYOU HEIGHTS, A NEW GATED TOWNHOME ENCLAVE IN PINELLAS PARK, FLORIDA
-
Moleculin to Report Full Year 2023 Financial Results on March 22, 2024 and Host Conference Call and Webcast
-
Dynacor Group Reports Sales of US$20.1 Million for February 2024 and Cumulative Sales of US$47.0 Million in 2024
-
A&W Restaurants Selects PAR Technology’s Data Central® to Propel Growth
-
Altimmune to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 27, 2024
-
Aterian Announces Reverse Stock Split
-
Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s Disease
-
Ollie’s Bargain Outlet Holdings, Inc. Reports Fourth Quarter and Fiscal 2023 Financial Results
-
Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
-
Aurora Spine Corporation Celebrates Second Anniversary of Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device
-
Titan Announces Q&A Session with Shareholders
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
FirstBank Puerto Rico Selects nCino to Transform Commercial Lending Services
-
23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
-
Optimove Launches OptiCircle, a Community to Empower Customers in CRM Marketing
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
-
SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results
-
Man Group PLC : Form 8.3 - Tritax Big Box REIT plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Direct Line Insurance Group plc - Ordinary Shares
-
Gold Hunter Announces Results of Shareholder Meeting and Corporate Updates
-
Lucinity Wins Workflow Automation Award in the Chartis Research FinCrime and Compliance 50 Ranking for 2024
-
Man Group PLC : Form 8.3 - Smith (DS) plc
-
Health and safety emerges as top risk facing global directors according to WTW’s and Clyde & Co’s latest survey
-
Health and safety emerges as top risk facing global directors according to WTW’s and Clyde & Co’s latest survey
-
2024 Vault Rankings: Kmind Tops“Best Consulting Firms in Asia-Pacific for Innovation”
-
Man Group PLC : Form 8.3 - Mondi plc
-
Form 8.3 - Tritax Big Box REIT PLC
-
Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance
-
Hamilton Zanze Announces Sale of BLVD at Medical Center
-
Spring Cleaning 2024: Tineco’s Promotions to Celebrate Spring
-
Ericsson appoints Andres Vicente Head of Market Area South East Asia, Oceania & India
-
2024 Relocation Trends | Energy & Utilities
-
Dimensional Fund Advisors Ltd. : Form 8.3 - CUSTODIAN PROPERTY INCOME RE - Ordinary Shares
-
7-Eleven, Inc. Reveals First Flavored Cold Brew Creations
-
HSBC Continental Europe: Pre Stabilisation Notice
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
Form 8.3 - UK Commercial Property REIT
-
Matrix Advises on the Sale of Andretti Petroleum Group to H&S Energy
-
Argyle welcomes former FHFA Chief Fintech Officer Jason Cave to board of advisors
-
Herbalife Announces CFO Transition; Initiates Guidance for First Quarter and Full-Year 2024
-
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer


